IOOF Holdings Limited (ASX: IFL) in an agreement with ANZ’s P&I businesses.


The company has been under an agreement to receive a partial economic interest of its Pensions and Investments (P&I) business and the legal ownership of its Aligned Dealer Groups (ADG) from October 1, 2018, as announced by ANZ after entering a non-binding term sheet. ANZ P&I business will receive an initial payment of $800 million from IOOF equivalent to approximately 82% of the economic interest.

Expected towards the end of the first half of 2019, there is no capital benefit until completion of the remaining P&I businesses. Earlier in 2007, ANZ announced the sale of the P&I and ADG businesses to IOOF. As at June 30, 2018, total FUMA was at $125.9 billion. Net inflows by segment for quarter to June 2018 is as follows – $2.5 billion for the quarter from advice, $666 million from the platform while investment management contributed $130 million.

The group reported for a record quarterly net flows of $3.2 billion in funds under management, administration and advice (FUMA) for the fourth quarter FY18. IFL is currently trading at a market price of $9.445 with a daily price change of $0.505 or a percentage change or rise of 5.6% as at July 26, 2018 before market close. The stock has however seen a performance change or decline of -8.31% over the past 12 months.

[pluginops_form template_id=’23834′ ]


Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report